| 证券代码: | 300151 | 证券简称：昌红科技 | 公告编号：2025-078 | | --- | --- | --- | --- | | 债券代码: | 123109 | 债券简称: 昌红转债 | | （一）本激励计划公开披露前，公司按照《内幕信息知情人管理制度》的要 求，限定内幕信息知情人范围，对参与本激励计划的商议筹划、论证咨询、决策 讨论等阶段的内幕信息知情人进行登记，采取严格保密措施，未发现信息泄露情 况。 深圳市昌红科技股份有限公司 关于 2025 年限制性股票激励计划激励对象及 内幕信息知情人买卖公司股票情况的自查报告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 深圳市昌红科技股份有限公司（以下简称"公司"）根据《上市公司股权激 励管理办法》《深圳证券交易所创业板上市公司自律监管指南第 1 号—业务办理》 《2025 年限制性股票激励计划（草案）》等相关规定，对 2025 年限制性股票激 励计划（以下简称"本激励计划"）相关人员买卖公司股票情况进行自查，具体 内容如下： 一、核查范围与程序 （一）核查对象为本激励计划的拟授予激励对象 ...

深圳市昌红科技股份有限公司董事会薪酬与考核委员会 深圳市昌红科技股份有限公司（以下简称"公司"）根据《上市公司股权激 励管理办法》《深圳证券交易所创业板上市公司自律监管指南第1号—业务办理》 《2025年限制性股票激励计划（草案）》等相关规定，对2025年限制性股票激励 计划（以下简称"本激励计划"）拟授予激励对象名单进行内部公示，公司董事 会薪酬与考核委员会结合公示情况进行核查并发表意见，具体内容如下： 一、公示情况 （一）公示内容：拟授予激励对象的姓名和职务。 （二）公示时间：2025年11月20日至2025年11月29日。 关于 2025 年限制性股票激励计划拟授予激励对象名单的 公示情况说明及核查意见 （三）公示方式：公司以张贴方式内部公示拟授予激励对象名单。 （四）反馈方式：公示期间，公司（含子公司）员工可通过电话、电子邮件 以及现场沟通等方式向公司董事会薪酬与考核委员会反馈相关情况，公司董事会 薪酬与考核委员会将做出适当记录。 （五）公示结果：公示期满，公司董事会薪酬与考核委员会未收到任何异议。 二、核查情况 公司董事会薪酬与考核委员会已对拟授予激励对象名单、激励对象的身份证 件、激励对象与公司（ ...

| 证券代码: | 300151 | 证券简称：昌红科技 | 公告编号：2025-077 | | --- | --- | --- | --- | | 债券代码: | 123109 | 债券简称: 昌红转债 | | 深圳市昌红科技股份有限公司 关于预计触发昌红转债转股价格向下修正条件的 提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 4、转股期限：2021 年 10 月 8 日至 2027 年 3 月 31 日 5、自 2025 年 11 月 17 日至 2025 年 11 月 28 日，公司股票已有 10 个交易日 的收盘价低于当期转股价格的 85%（即 22.71 元/股），预计触发"昌红转债"转股 价格向下修正条件。若触发条件，公司将于触发条件当日召开董事会审议决定是 否修正转股价格，并及时履行信息披露义务。 一、可转换公司债券基本情况 （一）可转换公司债券发行情况 经中国证券监督管理委员会出具的《关于同意深圳市昌红科技股份有限公司 向不特定对象发行可转换公司债券注册的批复》（证监许可〔2021〕609 号）核 准，公司本次可转换公 ...

Core Viewpoint - Changhong Technology experienced a slight decline in stock price, with significant trading activity and notable financing and margin trading metrics indicating a high level of investor interest and potential volatility in the near term [1][2]. Financing Summary - On November 17, Changhong Technology had a financing buy-in amount of 10.30 million yuan, with a net financing buy of 0.557 million yuan after accounting for repayments [1]. - The total financing balance reached 555.7 million yuan, representing 7.33% of the circulating market value, which is above the 60th percentile level over the past year, indicating a high financing level [1]. - Margin trading activity included a repayment of 200 shares and a sale of 300 shares, with a total selling amount of 4,272 yuan, while the margin balance stood at 1.209 million yuan, exceeding the 90th percentile level over the past year [1]. Business Performance - As of September 30, the number of shareholders increased to 24,400, while the average circulating shares per person decreased by 1.80% to 15,120 shares [2]. - For the period from January to September 2025, the company reported a revenue of 743 million yuan, a year-on-year decrease of 4.95%, and a net profit attributable to shareholders of 48.46 million yuan, down 40.47% year-on-year [2]. Dividend Information - Since its A-share listing, Changhong Technology has distributed a total of 555.7 million yuan in dividends, with 199.9 million yuan distributed over the past three years [3]. Shareholder Composition - As of September 30, 2025, the largest circulating shareholder was Hong Kong Central Clearing Limited, holding 4.5784 million shares, a decrease of 170,900 shares from the previous period [3]. - The Southern CSI 1000 ETF ranked as the eighth largest circulating shareholder with 2.9262 million shares, also showing a decrease of 16,600 shares [3].

Group 1 - The core viewpoint of the article is that Changhong Technology (SZ 300151) held its 19th meeting of the 6th board of directors on November 17, 2025, to discuss the proposal for the first extraordinary shareholders' meeting of 2025 [1] - For the year 2024, the revenue composition of Changhong Technology is as follows: OA industry accounts for 71.93%, medical industry accounts for 27.6%, and others account for 0.47% [1] - As of the time of reporting, the market capitalization of Changhong Technology is 7.6 billion yuan [1]

| 证券代码: | 300151 | 证券简称：昌红科技 | 公告编号：2025-076 | | --- | --- | --- | --- | | 债券代码: | 123109 | 债券简称: 昌红转债 | | 深圳市昌红科技股份有限公司 关于召开 2025 年第一次临时股东会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 1、股东会届次：2025 年第一次临时股东会 2、股东会的召集人：公司董事会。深圳市昌红科技股份有限公司（以下简 称"公司"或"本公司"）董事会于 2025 年 11 月 17 日召开了第六届董事会第十九 次会议审议通过《关于提请召开 2025 年第一次临时股东会的议案》，同意召开本 次股东会。 3、会议召开的合法、合规性：本次股东会会议的召集程序符合有关法律、 行政法规、部门规章、规范性文件和《公司章程》等规定。 4、会议召开的日期、时间： （1）现场会议时间：2025 年 12 月 3 日（星期三）14:00 （2）网络投票时间：2025 年 12 月 3 日 通过深圳证券交易所互联网投票系统投票的时间 ...

| 证券代码: | 300151 | 证券简称：昌红科技 | 公告编号：2025-075 | | --- | --- | --- | --- | | 债券代码: | 123109 | 债券简称: 昌红转债 | | 深圳市昌红科技股份有限公司 第六届董事会第十九次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、本次会议召开情况 1、审议并通过了《关于提请召开 2025 年第一次临时股东会的议案》 公司定于 2025 年 12 月 3 日（星期三）下午 14:00 在昌红医疗科技大厦 12 楼会议室召开 2025 年第一次临时股东会。 具体内容详见公司同日刊载在巨潮资讯网的《关于召开 2025 年第一次临时 股东会的通知》（公告编号：2025-076）。 1、深圳市昌红科技股份有限公司（以下简称"公司"）第六届董事会第十九 次会议（以下简称"本次会议"）于 2025 年 11 月 17 日上午在公司 12 楼 2 号会议 室以现场结合通讯表决方式召开。 2、本次会议通知时间及方式：会议通知于 2025 年 11 月 13 日以电子邮件及 短信等方 ...

| 证券代码:300151 | 证券简称：昌红科技 | 公告编号：2025-074 | | --- | --- | --- | | 债券代码:123109 | 债券简称：昌红转债 | | 深圳市昌红科技股份有限公司 关于 2022 年员工持股计划第三个锁定期届满的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 深圳市昌红科技股份有限公司（以下简称"公司"）于 2022 年 3 月 9 日召 开第五届董事会第十五次会议及第五届监事会第十三次会议，并于 2022 年 3 月 30 日召开 2022 年第一次临时股东大会，审议通过《关于公司<2022 年员工持股 计划（草案）>及其摘要的议案》《关于公司<2022 年员工持股计划管理办法> 的议案》《关于提请股东大会授权董事会办理员工持股计划相关事宜的议案》等 相关议案；于 2022 年 6 月 24 日召开第五届董事会第十九次会议及第五届监事会 第十六次会议，并于 2022 年 7 月 11 日召开 2022 年第二次临时股东大会，审议 通过《关于修订 2022 年员工持股计划相关事项的议案》。具体内容 ...

Quantitative Models and Construction - **Model Name**: DecompGRU **Model Construction Idea**: The model improves information interaction between time-series and cross-sectional data by introducing two simple de-mean modules on the GRU baseline model[18] **Model Construction Process**: 1. The DecompGRU model architecture is based on GRU as the baseline 2. Two de-mean modules are added to enhance the interaction between time-series and cross-sectional data 3. The model is trained using IC and weighted MSE loss functions[18] **Model Evaluation**: The model demonstrates improved interaction between time-series and cross-sectional data, enhancing prediction accuracy[18] Model Backtesting Results - **DecompGRU TOP200 Portfolio**: - Cumulative absolute return: 41.11% - Excess return relative to WIND All A equal-weight index: 13.98% - Maximum drawdown: 10.08% - Weekly win rate: 64.52% - Monthly win rate: 100% - October absolute return: 1.78%, excess return: -0.07%[11] - **ETF Rotation Portfolio**: - Cumulative absolute return: 19.06% - Excess return relative to benchmark: -2.00% - Maximum drawdown: 7.82% - Weekly win rate: 62.50% - Monthly win rate: 57.14% - October absolute return: -2.04%, excess return: -1.18%[14][15] Quantitative Factors and Construction - **Factor Name**: Sentiment Heat Factor **Factor Construction Idea**: The factor aggregates stock-level sentiment heat metrics (e.g., browsing, self-selection, and clicks) to represent broader market sentiment[19] **Factor Construction Process**: 1. Individual stock sentiment heat is calculated as the sum of browsing, self-selection, and click counts 2. The sentiment heat is normalized by dividing by the total market sentiment on the same day and multiplying by 10,000 3. Aggregated sentiment heat is used as a proxy for market sentiment at the index, industry, and concept levels[19] **Factor Evaluation**: The factor effectively captures market sentiment and its impact on pricing errors[19] Factor Backtesting Results - **Broad-based Index Sentiment Heat Rotation Strategy**: - Annualized return since 2017: 8.74% - Maximum drawdown: 23.5% - 2025 portfolio return: 38.5% - Benchmark return: 32.9%[28] - **Concept Sentiment Heat BOTTOM Portfolio**: - Annualized return: 15.71% - Maximum drawdown: 28.89% - 2025 portfolio return: 42.1%[41][44]

Core Viewpoint - Changhong Technology is a leading domestic high-end medical consumables company, focusing on polymer plastic consumables and OA equipment, with a differentiated advantage in integrated automation production solutions [1] Group 1: Business Performance - In Q3 2025, Changhong Technology reported revenue of 743 million yuan, ranking 40th in the industry, below the industry average of 1.21 billion yuan and the median of 596 million yuan [2] - The main business composition includes intelligent manufacturing products at 333 million yuan (66.94%), medical devices and consumables at 129 million yuan (25.87%), precision molds and automatic line equipment at 34.13 million yuan (6.86%), and others at 1.67 million yuan (0.34%) [2] - The net profit for the same period was 34.37 million yuan, ranking 45th in the industry, below the industry average of 111 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, the asset-liability ratio of Changhong Technology was 38.72%, lower than the industry average of 42.80%, indicating relatively good debt repayment ability [3] - The gross profit margin for Q3 2025 was 24.81%, down from 28.78% in the previous year and below the industry average of 28.52%, suggesting a need for improvement in profitability [3] Group 3: Executive Compensation - The chairman and general manager, Li Huanchang, received a salary of 1.17 million yuan in 2024, an increase of 473,500 yuan from 2023 [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders increased by 1.80% to 24,400, while the average number of circulating A-shares held per household decreased by 1.80% to 15,100 [5] Group 5: Market Outlook - In the first half of 2025, the company achieved revenue of 498 million yuan, a year-on-year increase of 2.95%, while net profit decreased by 28.6% to 31 million yuan [6] - The company is deepening global strategic cooperation, with the medical segment showing growth potential, becoming Roche's only medical consumables supplier outside Europe [6] - Revenue forecasts for 2025 to 2027 are 1.185 billion, 1.401 billion, and 1.687 billion yuan, with corresponding EPS of 0.24, 0.32, and 0.43 yuan [6]